Skip to main content
Erschienen in: Applied Health Economics and Health Policy 4/2020

01.08.2020 | Original Research Article

The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis

verfasst von: Vincenzo Alfano, Salvatore Ercolano

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

There has been much debate about the effectiveness of lockdown measures in containing COVID-19, and their appropriateness given the economic and social cost they entail. To the best of our knowledge, no existing contribution to the literature has attempted to gauge the effectiveness of lockdown measures over time in a longitudinal cross-country perspective.

Objectives

This paper aims to fill the gap in the literature by assessing, at an international level, the effect of lockdown measures (or the lack of such measures) on the numbers of new infections. Given this policy’s expected change in effectiveness over time, we also measure the effect of having a lockdown implemented over a given number of days (from 7 to 20 days).

Methods

We pursue our objectives by means of a quantitative panel analysis, building a longitudinal dataset with observations from countries all over the world, and estimating the impact of lockdown via feasible generalized least squares fixed effect, random effects, generalized estimating equation, and hierarchical linear models.

Results

Our results show that lockdown is effective in reducing the number of new cases in the countries that implement it, compared with those countries that do not. This is especially true around 10 days after the implementation of the policy. Its efficacy continues to grow up to 20 days after implementation.

Conclusion

Results suggest that lockdown is effective in reducing the R0, i.e. the number of people infected by each infected person, and that, unlike what has been suggested in previous analyses, its efficacy continues to hold 20 days after the introduction of the policy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Piguillem F, Shi L. The optimal covid-19 quarantine and testing policies (No. 2004). Einaudi Institute for Economics and Finance (EIEF). 2020 Piguillem F, Shi L. The optimal covid-19 quarantine and testing policies (No. 2004). Einaudi Institute for Economics and Finance (EIEF). 2020
3.
Zurück zum Zitat Figueiredo AM, Daponte Codina A, Figueiredo M, Saez M, Cabrera León A. Impact of lockdown on COVID-19 incidence and mortality in China: an interrupted time series study. Bull World Health Organ. Figueiredo AM, Daponte Codina A, Figueiredo M, Saez M, Cabrera León A. Impact of lockdown on COVID-19 incidence and mortality in China: an interrupted time series study. Bull World Health Organ.
4.
Zurück zum Zitat Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):37.CrossRef Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, et al. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020;27(3):37.CrossRef
8.
Zurück zum Zitat Cruz BS, de Oliveira Dias M. COVID-19: from outbreak to pandemic. Global Sci J. 2020;8(3). Cruz BS, de Oliveira Dias M. COVID-19: from outbreak to pandemic. Global Sci J. 2020;8(3).
9.
Zurück zum Zitat Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.CrossRef Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.CrossRef
10.
Zurück zum Zitat Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith H, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.CrossRef Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith H, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.CrossRef
11.
Zurück zum Zitat Aigner DJ, Balestra M. Optimal experimental design for error components models. Econometrica. 1988;56(4):955–71.CrossRef Aigner DJ, Balestra M. Optimal experimental design for error components models. Econometrica. 1988;56(4):955–71.CrossRef
12.
Zurück zum Zitat Hsiao C. Analysis of panel data. Cambridge: Cambridge University Press; 1986. Hsiao C. Analysis of panel data. Cambridge: Cambridge University Press; 1986.
13.
Zurück zum Zitat Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22.CrossRef Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22.CrossRef
14.
Zurück zum Zitat Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrika. 1986;42(1):121–30.CrossRef Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrika. 1986;42(1):121–30.CrossRef
15.
Zurück zum Zitat Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. Sage; 1992. Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. Sage; 1992.
Metadaten
Titel
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis
verfasst von
Vincenzo Alfano
Salvatore Ercolano
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Applied Health Economics and Health Policy / Ausgabe 4/2020
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-020-00596-3

Weitere Artikel der Ausgabe 4/2020

Applied Health Economics and Health Policy 4/2020 Zur Ausgabe